Y. Jacquot et al., Substituted benzopyranobenzothiazinones. Synthesis and estrogenic activityon MCF-7 breast carcinoma cells, EUR J MED C, 36(2), 2001, pp. 127-136
In the search for new agents with estrogenic activity mediated by estrogen
receptors (ER), six 6,12-dihydro-1-benzopyrano[3,4-b][1,4]benzothiazin-6-on
es 3a-f were synthesized. These compounds were readily prepared by the addi
tion of 2-aminothiophenol 2 to substituted 4-hydroxycoumarin derivatives la
-e. The estrogenic effect has been evaluated on the proliferation of MCF-7
breast adenocarcinoma cells and the specificity of described compounds was
evaluated by the inhibition of their effect by ICI 182,780, an antiestrogen
ic compound. Among the compounds tested, 6,12-dihydro-3-methoxy-1-benzopyra
no[3,4 b][1,4]benzothiazin-6-one 3e and 6,1 2-dihydro-3-hydroxy-1-benzopyra
no[3,4-b][1,4]benzothiazin-6-one 3f exhibited an ER-dependent proliferation
and a high binding affinity to ER, but a moderate capacity to activate the
transcription of a reporter gene. Their pharmacological profiles are defin
ed by their binding properties and their mechanism of action by computation
al modelling studies. (C) 2001 Editions scientifiques et medicales Elsevier
SAS.